Targeting the Immune System with Pharmacotherapy in Schizophrenia.

about

Targeting the Immune System with Pharmacotherapy in Schizophrenia.

Item

http://www.wikidata.org/entity/Q47837511

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Targeting the Immune System with Pharmacotherapy in Schizophrenia.

@en

Targeting the Immune System with Pharmacotherapy in Schizophrenia.

@nl

type

Item

label

Targeting the Immune System with Pharmacotherapy in Schizophrenia.

@en

Targeting the Immune System with Pharmacotherapy in Schizophrenia.

@nl

prefLabel

Targeting the Immune System with Pharmacotherapy in Schizophrenia.

@en

Targeting the Immune System with Pharmacotherapy in Schizophrenia.

@nl

P1476

Targeting the Immune System with Pharmacotherapy in Schizophrenia.

@en

P2093

Benjamin Feiner

http://www.w3.org/2001/XMLSchema#string

Cherise Rosen

http://www.w3.org/2001/XMLSchema#string

Jennifer K Melbourne

http://www.w3.org/2001/XMLSchema#string

Rajiv P Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data

The role of dehydroepiandrosterone (DHEA) in schizophrenia

Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review

Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

Putative neuroprotective agents in neuropsychiatric disorders

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update

The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

P2888

s40501-017-0114-0

P304

139-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40501-017-0114-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28674674

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

pharmacotherapy

P932

5493152

http://www.w3.org/2001/XMLSchema#string